# Intravesical Lactobacillus Crispatus: Clinical Safety and Microbiome Evaluation

> **NCT07308808** · EARLY_PHASE1 · RECRUITING · sponsor: **Medstar Health Research Institute** · enrollment: 40 (estimated)

## Conditions studied

- Spinal Cord Injuries (SCI)
- Neurogenic Bladder
- Urinary Tract Infection (Diagnosis)

## Interventions

- **DRUG:** Lactobacillus Crispatus
- **OTHER:** Saline bladder wash

## Key facts

- **NCT ID:** NCT07308808
- **Lead sponsor:** Medstar Health Research Institute
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-09-09
- **Primary completion:** 2027-03-30
- **Final completion:** 2027-03-30
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2025-12-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07308808

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07308808, "Intravesical Lactobacillus Crispatus: Clinical Safety and Microbiome Evaluation". Retrieved via AI Analytics 2026-07-13 from https://api.ai-analytics.org/clinical/NCT07308808. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*